Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression phenotype BEFREE DAX1 expressed a gradual increase from normal cervix to high-grade squamous intraepithelial lesions, and consequently to cervical cancer. 29497051 2018
CUI: C0677944
Disease: Sentinel node (disorder)
Sentinel node (disorder)
0.010 Biomarker disease BEFREE When patients with a positive SLN receive additional treatment to the at-risk nodal basin, both OS and DSS are similar to patients with a negative SLN. 29549898 2018
CUI: C2118460
Disease: Acute colitis
Acute colitis
0.010 Biomarker disease BEFREE Pathologically, Erbin expression in the intestinal mucosa was significantly decreased in DSS induced acute colitis mice, IL-10 deficient mice and clinical biopsy specimens from patients with ulcerative colitis. 29552291 2018
CUI: C2350019
Disease: Solitary Pulmonary Nodule
Solitary Pulmonary Nodule
0.010 Biomarker disease BEFREE DSS and OS of pancreatic head SPNs (HOP) were significantly shorter than those of other locations (OOP). 30057602 2018
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.010 AlteredExpression disease BEFREE DAX1 expressed a gradual increase from normal cervix to high-grade squamous intraepithelial lesions, and consequently to cervical cancer. 29497051 2018
CUI: C4696948
Disease: Trauma symptoms
Trauma symptoms
0.010 GeneticVariation phenotype BEFREE Questionnaires measuring trauma symptoms (HTQ), quality of life (WHO-5), dissociative symptoms (SDQ-20, DSS-20) and adult attachment (RAAS) are applied, as well as physiological measures (salivary oxytocin, beta-endorphin and substance P) and participant evaluation of each session. 29848343 2018
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE Atherosclerosis was induced by feeding high fat diet (HFD) to mice for 10 weeks, followed by five oral dosing with purified AHC or ovalbumin on alternate days and continued on HFD for another 10 weeks. 28638138 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE Atherosclerosis was induced by feeding high fat diet (HFD) to mice for 10 weeks, followed by five oral dosing with purified AHC or ovalbumin on alternate days and continued on HFD for another 10 weeks. 28638138 2017
CUI: C0007107
Disease: Malignant neoplasm of larynx
Malignant neoplasm of larynx
0.010 Biomarker disease BEFREE We evaluated the treatment outcomes among patients with T1aN0 laryngeal cancer with laryngectomy-free disease-specific survival (LFS-DSS), which is defined as time to total laryngectomy or time to death from cancer cause, against all other endpoints. 27778345 2017
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.010 AlteredExpression disease BEFREE In isolated primary Leydig cells from rats, BDE47 or insulin increased DAX-1 expression, decreased the expression of StAR and 3β-HSD, and reduced testosterone production, which was nearly reversed by knocking down DAX-1. 28300557 2017
CUI: C0030354
Disease: Papilloma
Papilloma
0.010 Biomarker disease BEFREE The DSS among all the hr-HPV+ patients was 78 % in the first period versus 77 % in the second period, while the OS was 71 versus 69 %, respectively. 27491318 2017
CUI: C0037221
Disease: Situs Inversus
Situs Inversus
0.010 Biomarker disease BEFREE Dextran sulfate sodium (DSS-exposure) is an established animal model for experimental colitis that was recently shown to recapitulate the link between GI-tract damage and pathogenic features of SIV infection. 28687795 2017
CUI: C0153382
Disease: Malignant neoplasm of oropharynx
Malignant neoplasm of oropharynx
0.010 Biomarker disease BEFREE Of note, OS and DSS of the patients with p16-negative OPC and heterozygous ALDH2 was significant poorer than those of the patients with p16-positive OPC (p = 0.002, 0.006, respectively), while there was no significant difference in OS and DSS between patients with p16-positive OPC and patients with p16-negative OPC and homozygous ALDH2. 29206831 2017
Secondary malignant neoplasm of bone
0.010 Biomarker disease BEFREE Survival analyses showed patients with ILC had a higher risk of liver metastasis (disease-specific survival[DSS]; P = 0.046), but had a better overall survival than the bone metastasis group (P<0.0001). 28863134 2017
CUI: C0206692
Disease: Carcinoma, Lobular
Carcinoma, Lobular
0.010 GeneticVariation disease BEFREE Survival analyses showed patients with ILC had a higher risk of liver metastasis (disease-specific survival[DSS]; P = 0.046), but had a better overall survival than the bone metastasis group (P<0.0001). 28863134 2017
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.010 AlteredExpression disease BEFREE Our findings designate NR0B1 as a druggable transcriptional regulator that supports NRF2-dependent lung cancers. 28965760 2017
CUI: C0338106
Disease: Adenocarcinoma of colon
Adenocarcinoma of colon
0.010 Biomarker disease BEFREE Recently, we undertook a pan-cancer analyses of the nuclear hormone receptor (NR) superfamily in The Cancer Genome Atlas (TCGA), and revealed that the vitamin D receptor (NR1I1/VDR) was commonly and significantly down-regulated specifically in colon adenocarcinoma cohort (COAD). 28027912 2017
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 AlteredExpression disease BEFREE High Ki-67 expression in localized PCa is a factor of poor prognosis for DSS, biochemical failure-free survival, DFS, DM, and OS after curative-intent treatments. 28648414 2017
Secondary malignant neoplasm of liver
0.010 GeneticVariation disease BEFREE Survival analyses showed patients with ILC had a higher risk of liver metastasis (disease-specific survival[DSS]; P = 0.046), but had a better overall survival than the bone metastasis group (P<0.0001). 28863134 2017
CUI: C0595989
Disease: Carcinoma of larynx
Carcinoma of larynx
0.010 Biomarker disease BEFREE We evaluated the treatment outcomes among patients with T1aN0 laryngeal cancer with laryngectomy-free disease-specific survival (LFS-DSS), which is defined as time to total laryngectomy or time to death from cancer cause, against all other endpoints. 27778345 2017
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 AlteredExpression disease BEFREE High Ki-67 expression in localized PCa is a factor of poor prognosis for DSS, biochemical failure-free survival, DFS, DM, and OS after curative-intent treatments. 28648414 2017
Chromosome 11p11.2 Deletion Syndrome
0.010 Biomarker disease BEFREE Smooth muscle cell migration was arrested in both the DSS and PSS-treated groups compared to that in the nontreated group (4.2% ± 0.31, 5.8% ± 0.60, 80.0% ± 4.4, respectively, n = 10, p < 0.05). 27615559 2017
CUI: C1849193
Disease: PEELING SKIN SYNDROME
PEELING SKIN SYNDROME
0.010 Biomarker disease BEFREE Smooth muscle cell migration was arrested in both the DSS and PSS-treated groups compared to that in the nontreated group (4.2% ± 0.31, 5.8% ± 0.60, 80.0% ± 4.4, respectively, n = 10, p < 0.05). 27615559 2017
CUI: C2349952
Disease: Oropharyngeal Carcinoma
Oropharyngeal Carcinoma
0.010 Biomarker disease BEFREE Of note, OS and DSS of the patients with p16-negative OPC and heterozygous ALDH2 was significant poorer than those of the patients with p16-positive OPC (p = 0.002, 0.006, respectively), while there was no significant difference in OS and DSS between patients with p16-positive OPC and patients with p16-negative OPC and homozygous ALDH2. 29206831 2017
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.010 Biomarker disease BEFREE DSS colitis phenotype was more severe in the ileocolic resection groups and this was associated with local and systemic immunosuppression as evidenced by a reduced cytokine responses to microbial stimuli. 28922370 2017